Serum iron and iron stores in non-anemic patients with fibromyalgia

Clinical Rheumatology

Volumn 31, Issue 4, 2012, Pages 595-599

  Mader, Reuven ^a,c   Koton, Yael ^a   Buskila, Dan ^b   Herer, Paula ^a   Elias, Mazen ^a,c  

^a HAEMEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Ferritin; Fibromyalgia; Iron; Transferrin receptors

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; FERRITIN; HEMOGLOBIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IRON; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; FIBROMYALGIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON STORAGE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL; VENOUS BLOOD;

ADULT; AGED; ANEMIA, IRON-DEFICIENCY; FEMALE; FERRITINS; FIBROMYALGIA; HUMANS; IRON; MALE; MIDDLE AGED; RECEPTORS, TRANSFERRIN;

EID: 84859779488     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1888-x     Document Type: Article

References (23)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160-172 (Pubitemid 20098653)
2. Branco JC, Bannwarth B, Failde I, Carbonell JA, Blotman F, Spaeth M, Saraiva F, Nacci F, Thomas E, Caubère JP, Le Lay K, Taieb C, Matucci-Cerinic M (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448-453
3. Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russel IJ, Humphrey L, Abetz L, Martin SA (2008) Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59:952-960 (Pubitemid 351990991)
4. Pamuk GE, On P, Set T, Harmandar O, Yesil N (2008) An increased prevalence of fibromyalgia in iron deficiency and thalassemia minor and associated factors. Clin Rheumatol 27:1103-1108
5. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL (1997) Prevalence of iron deficiency in the United States. JAMA 277:973-976 (Pubitemid 27142364)
6. Patterson AJ, Brown WJ, Roberts DCK (2001) Dietary and supplement treatment of iron deficiency results in improvements in general health and fatigue in Austrian women of childbearing age. J Am Coll Nutr 20:337-342 (Pubitemid 32744209)
7. Murray-Kolb LE, Beard JL (2007) Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 85:778-787 (Pubitemid 46393510)
8. Agarwal R (2007) Nonhematological benefits of iron. Am J Nephrol 27:565-571
9. Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H (2010) Association between serum ferritin level and fibromyalgia syndrome. Eur J Clin Nutr 64:308-312
10. Buskila D, Neumann L (1996) Assessing functional disability and health status of women with fibromyalgia: validation of a Hebrew version of the fibromyalgia impact questionnaire. J Rheumatol 23:903-906 (Pubitemid 26157769)
11. Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG (1998) Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 44:45-51 (Pubitemid 28042465)
12. Punnonen K, Irjala K, Rajamaki A (1997) Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood 89:1052-1057 (Pubitemid 27121300)
13. Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S et al (2007) Fibromyalgia syndrome. J Rheumatol 34:1415-1425 (Pubitemid 46898129)
14. Mease P (2005) Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl 75:6-21
15. Mease P, Arnold LM, Choy EH, Clauw DJ, Crofford L, Glass JM, OMERACT Fibromyalgia Working Group et al (2009) Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 36:2318-2329
16. Hudson JI, Arnold LM, Bradley LA, Choy EH, Mease PJ, Wang F et al (2009) What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine. J Rheumatol 36:2517-2522
17. Beard JL, Connor JR, Jones BC (1993) Iron in the brain. Nutr Rev 51:157-170 (Pubitemid 23247807)
18. Beard JL, Connor JR (2003) Iron status and neural functioning. Annu Rev Nutr 23:41-58 (Pubitemid 37059715)
19. Ortiz E, Pasquini JM, Thompson K, Felt B, Butkus G, Beard J, Connor JR (2004) Effect of manipulation of iron storage, transport, or availability on myelin composition and brain iron content in three different animal models. J Neurosci Res 75:681-689 (Pubitemid 39194609)
20. McCann JC, Ames BN (2007) An overview of evidence for a causal relation between iron deficiency during development and deficits in cognitive or behavioral function. Am J Clin Nutr 85:931-945 (Pubitemid 46557905)
21. Dowling P, Klinker F, Amaya F, Paulus W, Liebetanz D (2009) Iron deficiency sensitizes mice to acute pain stimuli and formalin induced nociception. J Nutr 139:2087-2092
22. Verdon F, Burnand B, Fallab Stubi CL, Bonard C, Graff M, Michaud A et al (2003) Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ 326:1124
23. Sun ER, Chen CA, Ho G, Earley CJ, Allen RP (1998) Iron and the restless legs syndrome. Sleep 21:371-377 (Pubitemid 128470320)